CDH13 and ovarian cancer: In the Module 76, miR-214, known to be involved in cell cycle, has been reported to be dys-regulated in ovarian cancer (Iorio et al., 2007; Nam et al., 2008; Yang et al., 2008), and CDH13 is a potential epigenetic biomarker for ovarian cancer (Wu et al., 2007).